NBCNBC News·6hHealth
score-0.60
FDA Requires GLP-1 Makers to Label Rare Eye Condition Risk
Original
FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
“The headline emphasizes a regulatory warning about a rare but severe side effect involving sudden blindness, evoking concern despite the low incidence rate.”